A citation-based method for searching scientific literature

Kimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, Yongjun Zhao, Kane Tse, Thomas Zeng, Janine Senz, Melissa K McConechy, Michael S Anglesio, Steve E Kalloger, Winnie Yang, Alireza Heravi-Moussavi, Ryan Giuliany, Christine Chow, John Fee, Abdalnasser Zayed, Leah Prentice, Nataliya Melnyk, Gulisa Turashvili, Allen D Delaney, Jason Madore, Stephen Yip, Andrew W McPherson, Gavin Ha, Lynda Bell, Sian Fereday, Angela Tam, Laura Galletta, Patricia N Tonin, Diane Provencher, Dianne Miller, Steven J M Jones, Richard A Moore, Gregg B Morin, Arusha Oloumi, Niki Boyd, Samuel A Aparicio, Ie-Ming Shih, Anne-Marie Mes-Masson, David D Bowtell, Martin Hirst, Blake Gilks, Marco A Marra, David G Huntsman. N Engl J Med 2010
Times Cited: 1042







List of co-cited articles
1024 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.
Siân Jones, Tian-Li Wang, Ie-Ming Shih, Tsui-Lien Mao, Kentaro Nakayama, Richard Roden, Ruth Glas, Dennis Slamon, Luis A Diaz, Bert Vogelstein,[...]. Science 2010
817
44

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, Alice Lee, Aimee M Near, Penelope M Webb, Christina M Nagle, Jennifer A Doherty, Kara L Cushing-Haugen, Kristine G Wicklund,[...]. Lancet Oncol 2012
530
19

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.
Ronald L Chandler, Jeffrey S Damrauer, Jesse R Raab, Jonathan C Schisler, Matthew D Wilkerson, John P Didion, Joshua Starmer, Daniel Serber, Della Yee, Jessie Xiong,[...]. Nat Commun 2015
161
19


ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
Jianfeng Shen, Yang Peng, Leizhen Wei, Wei Zhang, Lin Yang, Li Lan, Prabodh Kapoor, Zhenlin Ju, Qianxing Mo, Ie-Ming Shih,[...]. Cancer Discov 2015
219
17

Cancer-Associated Mutations in Endometriosis without Cancer.
Michael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, Tayyebeh M Nazeran, Michaël Noë, Hugo M Horlings, Amy Lum, Siân Jones, Janine Senz, Tamer Seckin,[...]. N Engl J Med 2017
249
16


Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
Benjamin G Bitler, Katherine M Aird, Azat Garipov, Hua Li, Michael Amatangelo, Andrew V Kossenkov, David C Schultz, Qin Liu, Ie-Ming Shih, Jose R Conejo-Garcia,[...]. Nat Med 2015
357
14

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
14

Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
14

Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
Kazuaki Suda, Hirofumi Nakaoka, Kosuke Yoshihara, Tatsuya Ishiguro, Ryo Tamura, Yutaro Mori, Kaoru Yamawaki, Sosuke Adachi, Tomoko Takahashi, Hiroaki Kase,[...]. Cell Rep 2018
127
13

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
Cigall Kadoch, Diana C Hargreaves, Courtney Hodges, Laura Elias, Lena Ho, Jeff Ranish, Gerald R Crabtree. Nat Genet 2013
671
13

ARID1A-mutated ovarian cancers depend on HDAC6 activity.
Benjamin G Bitler, Shuai Wu, Pyoung Hwa Park, Yang Hai, Katherine M Aird, Yemin Wang, Yali Zhai, Andrew V Kossenkov, Ana Vara-Ailor, Frank J Rauscher,[...]. Nat Cell Biol 2017
110
13

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
Kuan-Ting Kuo, Tsui-Lien Mao, Siân Jones, Emanuela Veras, Ayse Ayhan, Tian-Li Wang, Ruth Glas, Dennis Slamon, Victor E Velculescu, Robert J Kuman,[...]. Am J Pathol 2009
297
13


Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.
Kai Wang, Junsuo Kan, Siu Tsan Yuen, Stephanie T Shi, Kent Man Chu, Simon Law, Tsun Leung Chan, Zhengyan Kan, Annie S Y Chan, Wai Yin Tsui,[...]. Nat Genet 2011
512
12

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
John K Chan, Deanna Teoh, Jessica M Hu, Jacob Y Shin, Kathryn Osann, Daniel S Kapp. Gynecol Oncol 2008
267
12


ARID1A mutations in cancer: another epigenetic tumor suppressor?
Jennifer N Wu, Charles W M Roberts. Cancer Discov 2013
241
12

The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
Gautier Chene, Veronique Ouellet, Kurosh Rahimi, Veronique Barres, Diane Provencher, Anne Marie Mes-Masson. Int J Gynaecol Obstet 2015
42
26

Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma.
Atsuko Katagiri, Kentaro Nakayama, Mohammed Tanjimur Rahman, Munmun Rahman, Hiroshi Katagiri, Naomi Nakayama, Masako Ishikawa, Tomoka Ishibashi, Kouji Iida, Hiroshi Kobayashi,[...]. Mod Pathol 2012
132
10


Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
Melissa K McConechy, Jiarui Ding, Janine Senz, Winnie Yang, Nataliya Melnyk, Alicia A Tone, Leah M Prentice, Kimberly C Wiegand, Jessica N McAlpine, Sohrab P Shah,[...]. Mod Pathol 2014
135
10

Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.
Ryusuke Murakami, Noriomi Matsumura, J B Brown, Koichiro Higasa, Takanobu Tsutsumi, Mayumi Kamada, Hisham Abou-Taleb, Yuko Hosoe, Sachiko Kitamura, Ken Yamaguchi,[...]. Am J Pathol 2017
56
17


Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma.
Bin Guan, Tsui-Lien Mao, Pradeep K Panuganti, Elisabetta Kuhn, Robert J Kurman, Daichi Maeda, Elizabeth Chen, Yung-Ming Jeng, Tian-Li Wang, Ie-Ming Shih. Am J Surg Pathol 2011
179
9

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.
Chris T Williamson, Rowan Miller, Helen N Pemberton, Samuel E Jones, James Campbell, Asha Konde, Nicholas Badham, Rumana Rafiq, Rachel Brough, Aditi Gulati,[...]. Nat Commun 2016
148
9

ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
Jianfeng Shen, Zhenlin Ju, Wei Zhao, Lulu Wang, Yang Peng, Zhongqi Ge, Zachary D Nagel, Jun Zou, Chen Wang, Prabodh Kapoor,[...]. Nat Med 2018
173
9


Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
Ayse Ayhan, Tsui-Lien Mao, Tamer Seckin, Chen-Hsuan Wu, Bin Guan, Hiroshi Ogawa, Masayuki Futagami, Hiroki Mizukami, Yoshihito Yokoyama, Robert J Kurman,[...]. Int J Gynecol Cancer 2012
99
8

Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.
Michael S Anglesio, Ali Bashashati, Yi Kan Wang, Janine Senz, Gavin Ha, Winnie Yang, Mohamed R Aniba, Leah M Prentice, Hossein Farahani, Hector Li Chang,[...]. J Pathol 2015
77
10

ARID1B is a specific vulnerability in ARID1A-mutant cancers.
Katherine C Helming, Xiaofeng Wang, Boris G Wilson, Francisca Vazquez, Jeffrey R Haswell, Haley E Manchester, Youngha Kim, Gregory V Kryukov, Mahmoud Ghandi, Andrew J Aguirre,[...]. Nat Med 2014
213
8

Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.
Boris G Wilson, Xi Wang, Xiaohua Shen, Elizabeth S McKenna, Madeleine E Lemieux, Yoon-Jae Cho, Edward C Koellhoffer, Scott L Pomeroy, Stuart H Orkin, Charles W M Roberts. Cancer Cell 2010
366
8

SWI/SNF nucleosome remodellers and cancer.
Boris G Wilson, Charles W M Roberts. Nat Rev Cancer 2011
770
8

Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.
Nazar Mashtalir, Andrew R D'Avino, Brittany C Michel, Jie Luo, Joshua Pan, Jordan E Otto, Hayley J Zullow, Zachary M McKenzie, Rachel L Kubiak, Roodolph St Pierre,[...]. Cell 2018
171
8

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.
Hideaki Ogiwara, Kazuaki Takahashi, Mariko Sasaki, Takafumi Kuroda, Hiroshi Yoshida, Reiko Watanabe, Ami Maruyama, Hideki Makinoshima, Fumiko Chiwaki, Hiroki Sasaki,[...]. Cancer Cell 2019
80
10

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma.
Hiroaki Itamochi, Tetsuro Oishi, Nao Oumi, Satoshi Takeuchi, Kosuke Yoshihara, Mikio Mikami, Nobuo Yaegashi, Yasuhisa Terao, Kazuhiro Takehara, Kimio Ushijima,[...]. Br J Cancer 2017
37
21

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma,[...]. J Clin Oncol 2015
606
8

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
957
8

Mutational landscape and significance across 12 major cancer types.
Cyriac Kandoth, Michael D McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F McMichael, Matthew A Wyczalkowski,[...]. Nature 2013
8

Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis.
Bin Guan, Yohan Suryo Rahmanto, Ren-Chin Wu, Yihong Wang, Zhong Wang, Tian-Li Wang, Ie-Ming Shih. J Natl Cancer Inst 2014
74
10


Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.
Aikou Okamoto, Rosalind M Glasspool, Seiji Mabuchi, Noriomi Matsumura, Hiroyuki Nomura, Hiroaki Itamochi, Masashi Takano, Tadao Takano, Nobuyuki Susumu, Daisuke Aoki,[...]. Int J Gynecol Cancer 2014
74
9

Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.
Michael S Anglesio, Mark S Carey, Martin Köbel, Helen Mackay, David G Huntsman. Gynecol Oncol 2011
171
7

Endometriosis.
Krina T Zondervan, Christian M Becker, Kaori Koga, Stacey A Missmer, Robert N Taylor, Paola Viganò. Nat Rev Dis Primers 2018
292
7

Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition.
Eleftherios P Samartzis, Katrin Gutsche, Konstantin J Dedes, Daniel Fink, Manuel Stucki, Patrick Imesch. Oncotarget 2014
93
7

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.
Sohei Yamamoto, Hitoshi Tsuda, Masashi Takano, Seiichi Tamai, Osamu Matsubara. Virchows Arch 2012
73
9

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
7

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A Hoadley, Christina Yau, Toshinori Hinoue, Denise M Wolf, Alexander J Lazar, Esther Drill, Ronglai Shen, Alison M Taylor, Andrew D Cherniack, Vésteinn Thorsson,[...]. Cell 2018
647
7

Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress.
Ken Yamaguchi, Masaki Mandai, Shinya Toyokuni, Junzo Hamanishi, Toshihiro Higuchi, Kenji Takakura, Shingo Fujii. Clin Cancer Res 2008
198
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.